166 related articles for article (PubMed ID: 19291166)
21. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
22. False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal.
Alpert DR; Salmon JE
J Thromb Haemost; 2010 Jun; 8(6):1439-41. PubMed ID: 20345710
[No Abstract] [Full Text] [Related]
23. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
[TBL] [Abstract][Full Text] [Related]
24. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay.
Greinacher A; Amiral J; Dummel V; Vissac A; Kiefel V; Mueller-Eckhardt C
Transfusion; 1994 May; 34(5):381-5. PubMed ID: 8191560
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
[TBL] [Abstract][Full Text] [Related]
26. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
27. Heparin-induced thrombocytopenia: Diagnostic challenges in intensive care patients especially with extracorporeal circulation.
Althaus K; Straub A; Häberle H; Rosenberger P; Hidiatov O; Hammer S; Nowak-Harnau S; Enkel S; Riessen R; Bakchoul T
Thromb Res; 2020 Apr; 188():52-60. PubMed ID: 32059134
[TBL] [Abstract][Full Text] [Related]
28. Combination of 4Ts score and PF4/H-PaGIA for diagnosis and management of heparin-induced thrombocytopenia: prospective cohort study.
Linkins LA; Bates SM; Lee AY; Heddle NM; Wang G; Warkentin TE
Blood; 2015 Jul; 126(5):597-603. PubMed ID: 25926600
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT).
Sachs UJ; von Hesberg J; Santoso S; Bein G; Bakchoul T
Thromb Haemost; 2011 Dec; 106(6):1197-202. PubMed ID: 21979237
[TBL] [Abstract][Full Text] [Related]
30. Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review.
Warkentin TE; Greinacher A
Semin Thromb Hemost; 2023 Sep; 49(6):621-633. PubMed ID: 36455619
[TBL] [Abstract][Full Text] [Related]
31. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
32. Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory.
Nazi I; Arnold DM; Moore JC; Smith JW; Ivetic N; Horsewood P; Warkentin TE; Kelton JG
Am J Hematol; 2015 Jul; 90(7):629-33. PubMed ID: 25809312
[TBL] [Abstract][Full Text] [Related]
33. Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
Schönborn L; Esteban O; Wesche J; Dobosz P; Broto M; Puig SR; Fuhrmann J; Torres R; Serra J; Llevadot R; Palicio M; Wang JJ; Gordon TP; Lindhoff-Last E; Hoffmann T; Alberio L; Langer F; Boehme C; Biguzzi E; Grosse L; Endres M; Liman T; Thiele T; Warkentin TE; Greinacher A
Blood; 2023 Dec; 142(26):2305-2314. PubMed ID: 37883798
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
35. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of flow cytometric HIT assays in relation to an IgG-Specific immunoassay and clinical outcome.
Kerényi A; Beke Debreceni I; Oláh Z; Ilonczai P; Bereczky Z; Nagy B; Muszbek L; Kappelmayer J
Cytometry B Clin Cytom; 2017 Sep; 92(5):389-397. PubMed ID: 26860978
[TBL] [Abstract][Full Text] [Related]
37. FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Smith JW; Horsewood P; Moore JC; Warkentin TE; Crowther MA; Kelton JG
J Thromb Haemost; 2013 Jun; 11(6):1146-53. PubMed ID: 23551961
[TBL] [Abstract][Full Text] [Related]
38. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
Warkentin TE; Sheppard JI; Moore JC; Sigouin CS; Kelton JG
J Thromb Haemost; 2008 Aug; 6(8):1304-12. PubMed ID: 18489711
[TBL] [Abstract][Full Text] [Related]
39. High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies.
Garritsen HS; Probst-Kepper M; Legath N; Eberl W; Samaniego S; Woudenberg J; Schuitemaker JH; Kroll H; Gurney DA; Moore GW; Zehnder JL
Int J Lab Hematol; 2014 Apr; 36(2):135-43. PubMed ID: 23981347
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
